Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal lidocaine for benign headache in the emergency department
ACTRN12626000229370Phase 4Not yet recruiting
- Sponsor
- Ottawa Hospital Research Institute
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of lidocaine in Benign headache and migraine (2 arms), sponsored by Ottawa Hospital Research Institute. Primary endpoints: Feasibility and Pain at 30 minutes. Planned start May 2026; status: not yet recruiting.
02
Drugs
lidocaine
03
Conditions
Benign headachemigraine
Beyond the preview
Go deeper on ACTRN12626000229370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12626000229370.